1-9 of 9
Sylvain Pilorge
Close
Sort by
Journal Articles

The Impact of Risk-Adapted Treatment Strategy on Outcome of Patients with Acute Myeloid Leukemia Aged ≥ 60 Years after Allogeneic Stem Cell Transplantation

Riwa Sakr, MD, Sylvain Pilorge, MD, Stephane De Botton, Claude Chahine, MD, Tereza Coman, MD PhD, Marcel Adler, MD, Jean-Baptiste Micol, MD PhD, Florence Pasquier, MD PhD, Christophe Willekens, MD, Alina Danu, MD, Julien Lazarovici, MD, David Ghez, MD PhD, Eric Solary, MD, Vincent Ribbag, Jean-Henri Bourhis, Cristina Castilla-LLorente, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5544.
https://doi.org/10.1182/blood.V130.Suppl_1.5544.5544
Published: 2017
Journal Articles

Efficacy and Safety of Intensive Etoposide Aracytine Consolidation Following Rituximab Methotrexate Temozolomide Induction in Newly Diagnosed Primary Central Nervous System Lymphoma

Rudy Birsen, Estelle Blanc, MD, Barbara Burroni, MD, Chloe Broudin, MD, Lise Willems, MD, Marielle Legoff, MD, Emmanuelle Leray, MD, Sylvain Pilorge, MD, Sawsen Salah, MD, Aude Quentin, MD, Bénédicte Deau-Fisher, MD, Patricia Franchi, MD, Marguerite Vignon, MD, Laurence Mabille, MD, Charles Nguyen, MD, Youlia Kirova, MD, Pascale Varlet, MD, Arnault tauziede-Espariat, MD, Myriam Edjlali, MD, Dezamis Edouard, MD, Carole Soussain, MD PhD, Caroline Houillier, MD, Johan Pallud, MDPhD, Diane Damotte, MDPhD, Didier Bouscary, MDPhD, Jerome Tamburini Bonnefoy, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1573.
https://doi.org/10.1182/blood.V130.Suppl_1.1573.1573
Published: 2017
Journal Articles

Prognostic Value of Early 18F-FDG PET/CT Scanner Evaluation in Immunocompetent Primary CNS Lymphoma Patients

Rudy Birsen, Estelle Blanc, MD, Barbara Burroni, MD, Chloe Broudin, MD, Lise Willems, MD, Marielle Legoff, MD, Emmanuelle Leray, MD, Sylvain Pilorge, MD, Sawsen Salah, MD, Aude Quentin, MD, Bénédicte Deau-Fisher, MD, Patricia Franchi, MD, Marguerite Vignon, MD, Laurence Mabille, MD, Charles Nguyen, MD, Youlia Kirova, MD, Pascale Varlet, MD, Arnault tauziede-Espariat, MD, Myriam Edjlali, MD, Dezamis Edouard, MD, Khe Hoang-xuan, MD PhD, Caroline Houillier, MD, Carole Soussain, MD PhD, Johan Pallud, MDPhD, Diane Damotte, MDPhD, Didier Bouscary, MDPhD, Jerome Tamburini Bonnefoy, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4169.
https://doi.org/10.1182/blood.V130.Suppl_1.4169.4169
Published: 2017
Journal Articles

BEAM or BeEAM High-Dose Chemotherapy Followed By ASCT: A Single Center Comparative Analysis of Toxicity

Vincent Ribrag, MD, Khalil Saleh, MD, Alina Danu, MD, Serge Koscielny, Sylvain Pilorge, MD, Cristina castilla-Lorente, MD, David Ghez, Ph DMD, Julien Lazarovici, MD, Jean-Marie Michot, MD, Valerie Lapierre, PhD MD, Kamelia Alexandrova, Julia Arfi-Rouche, MD, Jean-Henri Bourhis, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4648.
https://doi.org/10.1182/blood.V128.22.4648.4648
Published: 2016
Journal Articles

Prognostic Significance of Karyotype in Octogenarian Patients (Pts) with Acute Myeloid Leukemia (AML)–An International Study

Meir Wetzler, MD, Jessica Kohlschmidt, PhD, Krzysztof Mrózek, MD, PhD, Herve Dombret, Hartmut Döhner, Prof. Dr. med., Sylvain Pilorge, Utz Krug, MD, Richard A. Larson, MD, Guido Marcucci, MD, Wolfgang Hiddemann, MD, Thomas Buchner, MD, Clara D. Bloomfield, MD
Journal: Blood
Blood (2011) 118 (21): 2521.
https://doi.org/10.1182/blood.V118.21.2521.2521
Published: 2011
Journal Articles

A Prospective Monocentric Study of Fractionated Gemtuzumab Ozogamicin (GO) Combined to Standard-Dose Cytarabine in Older Patients with Acute Myeloid Leukemia (AML) in First Relapse,

Sylvain Pilorge, Sophie Rigaudeau, Clémentine Sarkozy, Anne L Taksin, Hassan Farhat, Fatiha Merabet, Marcela Anitei, Stéphanie Ghez, Victoria Raggueneau, Isabel Garcia, Aline Renneville, Claude Preudhomme, Sylvie Castaigne, Philippe Rousselot, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3603.
https://doi.org/10.1182/blood.V118.21.3603.3603
Published: 2011
Journal Articles

Response to Azacytidine (AZA) in MDS or AML with Del 5q : Current Results of the French ATU Program

Raphael Itzykson, Sylvain Thépot, Claire Fabre, Francois Dreyfus, Bruno Quesnel, Eric Wattel, Stephane de Botton, Sylvain Pilorge, Caroline Dartigeas, Aspasia Stamatoullas, Thomas Prebet, Mario Ojeda-Uribe, Stéphane Cheze, Olivier Tournilhac, Eric Solary, Gandhi Damaj, Gerard Tertian, Chantal Himberlin, Rose-Marie Mbida, Blandine Beve, Lionel Adès, Claude Gardin, Pierre Fenaux
Journal: Blood
Blood (2008) 112 (11): 2682.
https://doi.org/10.1182/blood.V112.11.2682.2682
Published: 2008
Journal Articles

Treatment of Progression of Myeloproliferative Disorders(MPD) to MDS/AML by Azacytidine (AZA) : A Preliminary Report on 17 Patients (pts)

Sylvain Thépot, Raphael Itzykson, Emmanuel Raffoux, Murielle Roussel, Caroline Dartigeas, Francois Dreyfus, Christian Recher, Sylvain Pilorge, Bruno Cassinat, Blandine Beve, Rose-Marie Mbida, Jean-Jacques Kiladjian, Lionel Ades, Pierre Fenaux
Journal: Blood
Blood (2008) 112 (11): 2800.
https://doi.org/10.1182/blood.V112.11.2800.2800
Published: 2008
Journal Articles

High-Dose Methotrexate and Cytarabine Chemotherapy May Be Effective and Safe in Solid Organ Transplant Recipients with Primary CNS Lymphomas (PCNSL)

Laura Moise, M.D., Clemence Matta, Sylvain Pilorge, Marius Moldovan, Christophe Ferme, MD, Antoine Durrbach, Vincent Ribrag, MD
Journal: Blood
Blood (2008) 112 (11): 3611.
https://doi.org/10.1182/blood.V112.11.3611.3611
Published: 2008